Medical Procedure News

RSS

Potential medical and social barriers to resective epilepsy surgery in patients after initial evaluation

Epilepsy surgery is safe, effective and often curative in selected candidates. Although candidates for epilepsy surgery in the United States are estimated between 100,000 and 200,000, fewer than 5,000 such surgeries are conducted each year. The cause of this disparity is multi-factorial, including an unexplained low level of referrals by physicians and choices made by patients themselves.

5 Dec 2011

Vejthani Hospital offers Computer Assisted Replacement Surgery on knee arthroplasty

Vejthani Hospital Bangkok offers Computer Assisted Replacement Surgery on knee arthroplasty, the intelligent medical surgery software at TJR Center of Vejthani Hospital.

3 Dec 2011

Four clinical centers to provide NovoTTF device treatment for recurrent GBM

Novocure, a commercial stage private oncology company, has announced that prominent neuro-oncologists at four clinical centers in the U.S. will be the first to provide access to its Tumor Treating Fields (TTFields) device, NovoTTF-100A System, for the treatment of recurrent glioblastoma multiforme. GBM is a deadly brain tumor affecting approximately 10,000 Americans each year.

3 Dec 2011

Multidisciplinary prevention programme not effective in improving perceived employee health

Most of us would agree that prevention is better than cure. But new results out in the journal Clinical Rehabilitation, published by SAGE, indicate that a costly intervention programme designed to reduce early retirement on health grounds in Finland had no measurable effect.

3 Dec 2011

Better medical care for kidney failure in Germany

In complex cases of kidney failure, medical care in Germany evidently operates better than in the US. Scientists at Charité - Universitätsmedizin Berlin were able to show that German patients who have an increased risk of rejection reactions due to prior immunization have better survival rates than people with diseases of similar severity in the US.

3 Dec 2011

Implantable replacement cartilages hold promise for damaged knees, shoulders, ears and noses

A lab discovery is a step toward implantable replacement cartilage, holding promise for knees, shoulders, ears and noses damaged by osteoarthritis, sports injuries and accidents.

3 Dec 2011

Court OKs payment for bone marrow donation

A federal appeals court called bone marrow donation blood parts, not organ parts. The new reading of the federal prohibition could attract thousands more donors.

3 Dec 2011

FDA approves Mylan's Tranexamic Acid Injection ANDA

Mylan Inc. today announced that its business Mylan Institutional has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Tranexamic Acid Injection, 100 mg/mL, packaged in 1,000 mg/10 mL Single-dose Vials.

3 Dec 2011

University of Illinois Hospital prescribes Tumor Treating Fields therapy for recurrent GBM

The University of Illinois Hospital is the first center in North America to prescribe a new FDA-approved treatment for patients with the most common and aggressive type of brain tumor, glioblastoma multiforme, or GBM.

3 Dec 2011

Treatments for lymphoma with no side effects

Larry Conrad went in for his annual physical on his 50th birthday. During his exam, his doctor found swollen lymph nodes in his armpits and groin. Conrad had a cough and said he'd lost weight because he 'felt full all the time'. His doctor ordered a series of tests, and Conrad was diagnosed with Non-Hodgkin's lymphoma, the most common type.

2 Dec 2011

UA researchers receive NSF grant to develop terahertz spectral imager

Researchers at the University of Arizona College of Engineering have been awarded $530,000 to develop a unique piece of scientific equipment that will further spectral imaging research.

2 Dec 2011

NYU Langone establishes new LVAD Program for patients with advanced heart failure

The Cardiac & Vascular Institute at NYU Langone Medical Center has established its new LVAD Program. This surgical intervention program offers eligible, advanced heart failure patients implantation of the latest, lifesaving tool - a left ventricular assist device.

2 Dec 2011

Radioimmunotherapy shows promise against fungal diseases

Invasive fungal infections (IFI) are a major threat to individuals with cancer, transplants, HIV, and other conditions that weaken their immune system. New research has shown that radioimmunotherapy (RIT) could be a promising avenue for development of new types of treatment of fungal diseases, according to a paper published by scientists of the Joint Research Centre (JRC) in collaboration with other researchers.

2 Dec 2011

EGCG may prevent HCV reinfection after liver transplantation

German researchers have determined that epigallocatechin-3-gallate (EGCG)—a flavonoid found in green tea—inhibits the hepatitis C virus (HCV) from entering liver cells.

1 Dec 2011

FDA clears Covidien's SpiderFX embolic protection device

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has cleared SpiderFX for the treatment of severely calcified lesions used in conjunction with plaque excision in arteries of the lower extremities. It is the only embolic protection device indicated for this treatment in the United States.

1 Dec 2011

Yale researchers monitor growth of laboratory-engineered blood vessels after implantation

Using magnetic resonance imaging (MRI) and nanoparticle technology, researchers from Yale have devised a way to monitor the growth of laboratory-engineered blood vessels after they have been implanted in patients. This advance represents an important step toward ensuring that blood vessels, and possibly other tissues engineered from a patient's own biological material, are taking hold and working as expected.

1 Dec 2011

Study reveals no clear advantage of one implant type over another

More than 270,000 Americans get hip replacement surgeries every year -- a number that is projected to double in the next decade as the population ages. With various options for implants, including metal-on-polyethylene, metal-on-metal and ceramic-on-ceramic, there have been questions about which kind works best.

1 Dec 2011

GE Healthcare announces interoperable visualization and image management applications at RSNA 2011

Today at RSNA 2011, GE Healthcare announced a leap forward in radiology department workflow with an interoperable suite of advanced visualization and image management applications.

1 Dec 2011

Immune system stimulant used as suppressor to treat chronic graft-versus-host disease

In a study that seems to pivot on a paradox, scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients. The effect, in some cases, was profound.

1 Dec 2011

Combination of two techniques promises to improve effectiveness of experimental gene therapies

yeast or phages act not only to tag and target but also to exchange specific genes in DNA A combination of two techniques promises to improve the efficiency and effectiveness of experimental gene therapies, while also reducing potential side effects says a new research report published in the December 2011 issue of the FASEB Journal.

1 Dec 2011

Medical Procedure News

Potential medical and social barriers to resective epilepsy surgery in patients after initial evaluation

Vejthani Hospital offers Computer Assisted Replacement Surgery on knee arthroplasty

Four clinical centers to provide NovoTTF device treatment for recurrent GBM

Multidisciplinary prevention programme not effective in improving perceived employee health

Better medical care for kidney failure in Germany

Implantable replacement cartilages hold promise for damaged knees, shoulders, ears and noses

Court OKs payment for bone marrow donation

FDA approves Mylan's Tranexamic Acid Injection ANDA

University of Illinois Hospital prescribes Tumor Treating Fields therapy for recurrent GBM

Treatments for lymphoma with no side effects

UA researchers receive NSF grant to develop terahertz spectral imager

NYU Langone establishes new LVAD Program for patients with advanced heart failure

Radioimmunotherapy shows promise against fungal diseases

EGCG may prevent HCV reinfection after liver transplantation

FDA clears Covidien's SpiderFX embolic protection device

Yale researchers monitor growth of laboratory-engineered blood vessels after implantation

Study reveals no clear advantage of one implant type over another

GE Healthcare announces interoperable visualization and image management applications at RSNA 2011

Immune system stimulant used as suppressor to treat chronic graft-versus-host disease

Combination of two techniques promises to improve effectiveness of experimental gene therapies

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News